GlassScriptPhysician profile
Love Dalal
NPI 1992768360
$1,949.09
in general payments reported to CMS, 2019-2025
19 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.23 · 2020: $85.93 · 2022: $67.08 · 2023: $116 · 2024: $465 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,540 · Education: $119 · Gift: $79.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.87 |
| Education | $119.29 |
| Gift | $79.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $610.55 | 2019-2025 | Linzess |
| Janssen Biotech, INC. | $422.43 | 2024-2025 | Tremfya, Stelara |
| Boston Scientific Corporation | $183.16 | 2025 | Axios |
| Braintree Laboratories, INC. | $124.12 | 2020-2023 | Sutab |
| Ipsen Biopharmaceuticals, INC | $101.71 | 2025 | Iqirvo, Bylvay |
| Madrigal Pharmaceuticals | $87.91 | 2024 | Rezdiffra |
| Lilly USA, LLC | $74.24 | 2025 | Omvoh |
| Exact Sciences Corporation | $62.17 | 2024 | Cologuard Collection Kit |
| Olympus America INC. | $50.47 | 2022-2024 | Endoclot Phs, Visiglide |
| Novo Nordisk INC | $49.45 | 2025 | Wegovy |
| Celgene Corporation | $39.11 | 2022 | |
| Daiichi Sankyo INC. | $29.23 | 2019 | |
| Aimmune Therapeutics, INC. | $24.06 | 2025 | Vowst |
| Pfizer INC. | $21.73 | 2025 | |
| Organon LLC | $15.62 | 2025 | Hadlima |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $14.82 | 2025 | Dupixent |
| Gilead Sciences, INC. | $14.50 | 2022 | |
| Covidien LP | $13.33 | 2020 | |
| Janssen Pharmaceuticals, INC | $10.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Love Dalal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.